HIV screening: better communication instead of searching for a needle in a haystack?

Most read articles by the same author(s)

• Axel J. Schmidt, Manuela Rasi, Cate Esson, Vanessa Christinet, Michael Ritzler, Thomas Lung, Christoph V. Hauser, Marcel Stoeckle, Florent Jouinot, Andreas Lehner, Katharina Lange, Torsten Konrad, Pietro Vernazza, The Swiss STAR trial – an evaluation of target groups for sexually transmitted infection screening in the sub-sample of men , Swiss Medical Weekly: Vol. 150 No. 5153 (2020)
• Pietro Vernazza, Manuela Rasi, Michael Ritzler, Ferah Dost, Milena Stoffel, Karoline Aebi-Popp, Christoph V. Hauser, Cate Esson, Katharina Lange, Lorenz Risch, Axel J. Schmidt, The Swiss STAR trial – an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women , Swiss Medical Weekly: Vol. 150 No. 5153 (2020)
• Sarah L. Thiel, Myriam C. Weber, Lorenz Risch, Nadia Wohlwend, Thomas Lung, Dorothea Hillmann, Michael Ritzler, Martin Risch, Philipp Kohler, Pietro Vernazza, Christian R Kahlert, Felix Fleisch, Alexia Cusini, Tomas V. Karajan, Sandra Copeland, Matthias Paprotny, Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein – an observational study , Swiss Medical Weekly: Vol. 150 No. 4142 (2020)
• Christian R. Kahlert, Karoline Aebi-Popp, Enos Bernasconi, Begoña Martinez de Tejada, David Nadal, Paolo Paioni, Christoph Rudin, Cornelia Staehelin, Noémie Wagner, Pietro Vernazza, Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting? , Swiss Medical Weekly: Vol. 148 No. 2930 (2018)
• Pietro Vernazza, Edwin J. Bernard, HIV is not transmitted under fully suppressive therapy: The Swiss Statement – eight years later , Swiss Medical Weekly: Vol. 146 No. 0304 (2016)
• Andrea Bregenzer, Philip Bruggmann, Erika Castro, Alberto Moriggia, Madeleine Rothen, Maria Christine Thurnheer, Pietro Vernazza, Claude Scheidegger, Hepatitis C virus elimination in Swiss opioid agonist therapy programmes – the SAMMSU cohort , Swiss Medical Weekly: Vol. 151 No. 0910 (2021)
• Kerstin Wissel, Pietro Vernazza, Stefan Kuster, Katharina Hensel-Koch, Andrea Bregenzer, Hepatitis C prevalence and cascade of care among patients in the decentralised opioid agonist therapy programme of the canton of St Gallen, Switzerland: a cross-sectional study , Swiss Medical Weekly: Vol. 154 No. 2 (2024)
• Selina Albrecht, Fabian Grässli, Alexia Cusini, Angela Brucher, Stephan Goppel, Elsbeth Betschon, J. Carsten Möller, Manuela Ortner, Markus Ruetti, Reto Stocker, Danielle Vuichard-Gysin, Ulrike Besold, Lorenz Risch, Matthias von Kietzell, Matthias Schlegel, Pietro Vernazza, Stefan P. Kuster, Christian R. Kahlert, Philipp Kohler, SARS-CoV-2 immunity and reasons for non-vaccination among healthcare workers from eastern and northern Switzerland: results from a nested multicentre cross-sectional study , Swiss Medical Weekly: Vol. 154 No. 4 (2024)
• Urs Rusch, Sarah Robbins, Homie Razavi, Pietro Vernazza, Sarah Blach, Philip Bruggmann, Beat Müllhaupt, Francesco Negro, David Semela, Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions , Swiss Medical Weekly: Vol. 149 No. 0304 (2019)
• Annalisa Marinosci, Delphine Sculier, Gilles Wandeler, Sabine Yerly, Marcel Stoeckle, Enos Bernasconi, Dominique L. Braun, Pietro Vernazza, Matthias Cavassini, Marta Buzzi, Karin J. Metzner, Laurent Decosterd, Huldrych F. Günthard, Patrick Schmid, Andreas Limacher, Mattia Branca, Alexandra Calmy, Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL’HIV open-label, factorial randomised controlled trial , Swiss Medical Weekly: Vol. 154 No. 4 (2024)